---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-149139"
form_type: "8-K"
ticker: "VIR"
cik: "0001706431"
company_name: "Vir Biotechnology, Inc."
filed_at: "2024-05-29T23:59:59+00:00"
generated_at: "2026-06-01T07:42:32.658946+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Vir Biotechnology shareholders elect Class II directors, approve advisory compensation, ratify EY

## Summary
- Directors De Backer, Bischofberger, Farid, Nelsen elected with votes for/withheld: 105.6M/1.1M, 80.0M/26.7M, 106.4M/0.3M, 67.9M/38.8M; broker non-votes 12.3M.
- Advisory vote on executive compensation approved: 83.9M for, 22.6M against, 0.2M abstain; broker non-votes 12.3M.
- Ratification of Ernst & Young as auditor: 118.1M for, 679,046 against, 168,971 abstain; no broker non-votes.

## SEC filing metadata
- accession: 0001193125-24-149139
- form_type: 8-K
- ticker: VIR
- cik: 0001706431
- company_name: Vir Biotechnology, Inc.
- filed_at: 2024-05-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1706431/000119312524149139/0001193125-24-149139-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1706431/000119312524149139/d771470d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-149139
- JSON: https://secwatch.observer/filing/0001193125-24-149139.json
- Plain text: https://secwatch.observer/filing/0001193125-24-149139.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.